Danaher | Passivo Circulante



Current Liabilities Alterar Data
Abbott USD 14.16B 745M 2024-12
Agilent USD 1.87B 26M 2025-01
Align Technology USD 2.04B 25.59M 2024-12
Becton, Dickinson and Co. USD 7.66B 1.29B 2024-12
Bio Techne USD 161.26M 19.13M 2024-12
Bio-Rad Laboratories USD 467.8M 30.14M 2024-12
Boston Scientific USD 6.4B 489M 2024-12
Bruker USD 1.28B 37.5M 2024-12
Charles River Laboratories USD 994.1M 18.12M 2024-12
Danaher USD 6.8B 541M 2024-12
Dentsply International USD 1.59B 47M 2024-12
Edwards Lifesciences USD 1.51B 438.9M 2024-12
ESCO Technologies USD 316.11M 33.74M 2024-12
Exact Sciences USD 732.19M 8.52M 2024-12
Fortive USD 2.24B 137.6M 2024-12
Henry Schein USD 2.8B 126M 2024-12
Hologic USD 1B 34.8M 2024-12
Illumina USD 1.55B 572M 2024-12
Intuitive Surgical USD 2.21B 536.8M 2024-12
IQVIA Holdings USD 6.96B 35M 2024-12
Keysight Technologies USD 1.51B 82M 2025-01
Laboratory Of America USD 3.33B 81.8M 2024-12
Medtronic USD 11.84B 355M 2025-01
Mettler Toledo International USD 1.17B 16.77M 2024-12
Myriad Genetics USD 164.1M 9.8M 2024-12
Patterson Companies USD 1.31B 39.02M 2025-01
Quest Diagnostics USD 2.17B 77M 2024-12
Quidel USD 998.8M 28.5M 2024-12
Repligen USD 108.37M 65.94M 2024-09
Revvity USD 653.1M 34.84M 2024-12
Roper Industries USD 3.83B 542.5M 2024-12
Stryker USD 7.62B 53M 2024-12
Thermo Fisher Scientific USD 13.33B 1.27B 2024-12
Waters USD 789.76M 26.28M 2024-12
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12



Danaher Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.